Scarica l'app Stockscreener
5.46
1.68%
0.09
Dopo l'orario di chiusura:
5.55
0.09
+1.65%
Precedente Chiudi:
$5.37
Aprire:
$5.47
Volume 24 ore:
451.72K
Relative Volume:
0.33
Capitalizzazione di mercato:
$198.30M
Reddito:
$317.00K
Utile/perdita netta:
$-53.47M
Rapporto P/E:
-2.8889
EPS:
-1.89
Flusso di cassa netto:
$-49.31M
1 W Prestazione:
-2.50%
1M Prestazione:
+59.18%
6M Prestazione:
+268.92%
1 anno Prestazione:
+336.80%
Intervallo 1D:
$5.305
$5.53
Intervallo di 1 settimana:
$5.165
$6.35
Portata 52W:
$1.10
$6.35
Immuneering Corp Stock (IMRX) Company Profile
Nome
Immuneering Corp
Settore
Industria
Telefono
617-500-8080
Indirizzo
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE
Confronta IMRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMRX
Immuneering Corp
|
5.46 | 255.46M | 317.00K | -53.47M | -49.31M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Immuneering Corp Stock (IMRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-13 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-03-15 | Downgrade | Jefferies | Buy → Hold |
| 2024-03-15 | Reiterato | Needham | Buy |
| 2024-03-15 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-01 | Iniziato | Needham | Buy |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2023-04-19 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-04-19 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2023-03-30 | Iniziato | Mizuho | Neutral |
| 2023-02-03 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-07-08 | Iniziato | Chardan Capital Markets | Buy |
| 2022-04-01 | Iniziato | Oppenheimer | Outperform |
| 2022-01-07 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Immuneering Corp Borsa (IMRX) Ultime notizie
Can Immuneering Corporation ride the EV waveJuly 2025 Closing Moves & Free Weekly Watchlist of Top Performers - khodrobank.com
Immuneering Corporation (IMRX) files for up to 9.18M share offering by selling stockholders - StreetInsider
Custom watchlist performance reports with Immuneering Corporation2025 Geopolitical Influence & Daily Chart Pattern Signals - Newser
Buyback Watch: Can Immuneering Corporation deliver consistent dividends2025 Growth vs Value & Verified Swing Trading Watchlist - khodrobank.com
Can a trend reversal in Immuneering Corporation lead to recoveryJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - Newser
Order flow analysis tools used on Immuneering CorporationWeekly Gains Summary & High Conviction Trade Alerts - Newser
How hedge fund analytics apply to Immuneering Corporation stockMarket Movement Recap & Daily Profit Focused Stock Screening - Newser
Building trade automation scripts for Immuneering CorporationBreakout Watch & Safe Swing Trade Setups - Newser
What momentum shifts mean for Immuneering CorporationRisk Management & Technical Pattern Alert System - Newser
Is Immuneering Corporation a cyclical or defensive stockShort Setup & Growth Oriented Trading Recommendations - khodrobank.com
Understanding Immuneering Corporation’s price movementJuly 2025 Market Mood & Technical Pattern Recognition Alerts - Newser
Does Immuneering Corporation show high probability of reboundShare Buyback & Daily Oversold Bounce Ideas - Newser
Can Immuneering Corporation recover in the next quarterJuly 2025 Institutional & Fast Momentum Stock Entry Tips - Newser
Tick level data insight on Immuneering Corporation volatilityCPI Data & Fast Gaining Stock Strategy Reports - Newser
What machine learning models say about Immuneering CorporationOil Prices & Real-Time Stock Entry Alerts - Newser
Is Immuneering Corporation stock entering bullish territoryQuarterly Performance Summary & Fast Momentum Entry Tips - Newser
Can Immuneering Corporation expand into new markets2025 Breakouts & Breakdowns & Smart Investment Allocation Tips - kpenews.com
Leading vs lagging indicators on Immuneering Corporation performance2025 Technical Overview & Stepwise Trade Execution Plans - Newser
Published on: 2025-08-29 00:05:44 - Newser
Live market analysis of Immuneering CorporationTake Profit & Growth Focused Stock Pick Reports - Newser
Published on: 2025-08-28 12:45:47 - Newser
Using Python tools to backtest Immuneering Corporation strategiesPortfolio Update Report & Verified Momentum Stock Alerts - Newser
Immuneering Corporation stock prediction for this weekJuly 2025 Retail & AI Forecasted Entry and Exit Points - Newser
How Immuneering’s financial strategy fuels scientific breakthroughs - BioXconomy
Immuneering (NASDAQ:IMRX) Receives “Buy” Rating from Needham & Company LLC - Defense World
Immuneering Corp Azioni (IMRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Immuneering Corp Azioni (IMRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| HAUSMAN DIANA | Director |
Jul 02 '25 |
Buy |
3.60 |
2,500 |
8,989 |
2,500 |
| Neufeld Leah R | CHIEF PEOPLE OFFICER |
Jul 02 '25 |
Buy |
3.57 |
700 |
2,499 |
10,729 |
| Zeskind Benjamin J. | PRESIDENT AND CEO |
Jul 02 '25 |
Buy |
3.53 |
7,015 |
24,792 |
2,312,852 |
| Zeskind Benjamin J. | PRESIDENT AND CEO |
Jul 01 '25 |
Buy |
3.38 |
2,985 |
10,087 |
2,305,837 |
| Schall Thomas J. | Director |
Jun 27 '25 |
Buy |
3.66 |
9,500 |
34,788 |
52,885 |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER |
Jun 20 '25 |
Buy |
2.70 |
7,415 |
20,020 |
353,311 |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER |
Jun 23 '25 |
Buy |
2.43 |
6,007 |
14,596 |
359,318 |
| Brakewood Harold Eugene | Chief Business Officer |
Jun 20 '25 |
Buy |
2.53 |
1,900 |
4,804 |
5,800 |
| Feinberg Peter | Director |
Jun 18 '25 |
Buy |
2.53 |
25,000 |
63,188 |
136,766 |
| Zeskind Benjamin J. | PRESIDENT AND CEO |
Jun 18 '25 |
Buy |
2.39 |
21,000 |
50,144 |
2,302,852 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):